Image For Activity Cover
Meeting State Requirements for Pain/Opiate Education for the Nurse Practitioner and Nurse Practitioner Students
Kathleen Bradbury-Golas, DNP, RN, APRN, ACNS-BC, Associate Professor of Nursing, Drexel University, College of Nursing and Health Professions, Philadelphia, PA
Target Audience
This activity was developed to meet the needs of Nurse Practitioners and Nurses caring for clients with substance use disorders.
Webinar Description
Secondary to the opioid epidemic in the United States, more and more states are now mandating continuing education on pain management and opioids for initial licensure and licensure renewal for nurse practitioners and nurse practitioner students. This presentation will specifically focus on development of an on-line educational program on pain management and opioid education for nurse practitioners and nurse practitioner students. The Board of Nursing in Pennsylvania now has state mandated requirements for education on pain management and opioid education for initial licensure and re-licensure of nurse practitioners. Drexel University, College of Nursing & Health Professions developed a curriculum to meet the mandated required hours of education. This presentation will discuss curriculum development and content of the modules as well as the state approval process.
Webinar Description

At the conclusion of this activity, learners should be able to:

  • Identify the steps to creating an outline pain management/opiate education module for NP students.
  • Review statistics of a created program.
  • Discuss the requirements for continuing education for Advanced Practice Nurses and students to initiate/renew licensure.
Availability: Retired
Cost: FREE
Credit Offered:
No Credit Offered
The content on this site is intended solely to inform and educate medical professionals. This site shall not be used for medical advice and is not a substitute for the advice or treatment of a qualified medical professional.

Funding for this initiative was made possible (in part) by grant nos. 1H79TI086770 and 1H79TI085588 from SAMHSA. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.

For Buprenorphine Training Inquiries, email PCSS-MOUD.


Powered By